Telangana GST Authority Upholds Rs 4.60 Crore ITC Demand Against Aurobindo Pharma
Aurobindo Pharma's stock declined 1.4% following an adverse order by the Telangana GST appellate authority confirming a Rs 4.60 crore demand related to excess input tax credit (ITC) claimed for the 2020-21 financial year. The order, issued by the Appellate Joint Commissioner in Hyderabad, includes Rs 2.56 crore in alleged excess ITC, Rs 1.78 crore interest, and a Rs 25.64 lakh penalty. The company plans to appeal the decision and does not expect significant impact on its operations or financial performance.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (46/100). Lens Score 41/100.
Outlets measured: freepressjournal, moneycontrol. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (45–48/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
moneycontrol broke this story on 30 Sept, 04:28 am. Other outlets followed.